How many drugs treat Cholelithiasis Prevention?

Drug Landscape tracks 2 marketed treatments for Cholelithiasis Prevention (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/cholelithiasis-prevention.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Cholelithiasis Prevention — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Cholelithiasis Prevention (disease) competitive landscape: 2 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

2 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Cholelithiasis Prevention, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	Line of therapy	First approval
Actigall	URSODIOL	AbbVie	Bile Acid [EPC]	CDGSH iron-sulfur domain-containing protein 1		1987-01-01
Ursolvan	Ursolvan	Hopital Foch		Aldo-keto reductase family 1 member C2, CDGSH iron-sulfur domain-containing protein 1, Ectonucleotide pyrophosphatase/phosphodiesterase family member 2

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

AbbVie · 1 drug in Cholelithiasis Prevention
Hopital Foch · 1 drug in Cholelithiasis Prevention

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Cholelithiasis Prevention:

Cite this brief

Drug Landscape (2026). Cholelithiasis Prevention — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/cholelithiasis-prevention. Accessed 2026-06-10.

Cholelithiasis Prevention full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing